Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$873M Sell
6,793,897
-763,621
-10% -$89.4M 0.17% 78
2026
Q1
$909M Buy
7,557,518
+2,783,832
+58% +$321M 0.22% 64
2025
Q4
$502M Sell
4,773,686
-2,739,201
-36% -$257M 0.12% 121
2025
Q3
$631M Buy
7,512,887
+1,616,919
+27% +$133M 0.14% 96
2025
Q2
$467M Buy
5,895,968
+39,116
+0.7% +$3.11M 0.11% 121
2025
Q1
$526M Sell
5,856,852
-609,159
-9% -$56.9M 0.15% 99
2024
Q4
$643M Sell
6,466,011
-421,564
-6% -$43.5M 0.18% 64
2024
Q3
$782M Sell
6,887,575
-1,157,249
-14% -$137M 0.21% 62
2024
Q2
$996M Sell
8,044,824
-626,983
-7% -$80.8M 0.3% 39
2024
Q1
$1.14B Buy
8,671,807
+3,196,476
+58% +$394M 0.4% 36
2023
Q4
$597M Sell
5,475,331
-1,277,952
-19% -$133M 0.22% 73
2023
Q3
$695M Sell
6,753,283
-501,631
-7% -$54.1M 0.43% 36
2023
Q2
$837M Buy
7,254,914
+4,690,304
+183% +$533M 0.53% 30
2023
Q1
$273M Sell
2,564,610
-5,620,218
-69% -$607M 0.13% 99
2022
Q4
$908M Buy
8,184,828
+3,912,091
+92% +$400M 0.41% 24
2022
Q3
$368M Buy
4,272,737
+1,511,286
+55% +$135M 0.4% 43
2022
Q2
$252M Sell
2,761,451
-1,491,438
-35% -$132M 0.15% 95
2022
Q1
$349M Sell
4,252,889
-4,402,826
-51% -$347M 0.27% 74
2021
Q4
$663M Buy
8,655,715
+1,961,749
+29% +$156M 0.25% 72
2021
Q3
$503M Buy
6,693,966
+1,985,377
+42% +$151M 0.23% 72
2021
Q2
$366M Buy
4,708,589
+800,921
+20% +$59.6M 0.17% 85
2021
Q1
$287M Buy
3,907,668
+876,554
+29% +$64.7M 0.15% 96
2020
Q4
$237M Sell
3,031,114
-939,389
-24% -$71.8M 0.13% 125
2020
Q3
$314M Buy
3,970,503
+2,003,161
+102% +$157M 0.19% 88
2020
Q2
$145M Sell
1,967,342
-660,897
-25% -$49.8M 0.11% 134
2020
Q1
$193M Sell
2,628,239
-3,200,326
-55% -$252M 0.15% 91
2019
Q4
$506M Buy
5,828,565
+925,223
+19% +$76M 0.28% 62
2019
Q3
$394M Buy
4,903,342
+102,310
+2% +$8.2M 0.25% 67
2019
Q2
$384M Sell
4,801,032
-220,743
-4% -$16.9M 0.24% 67
2019
Q1
$399M Buy
5,021,775
+106,206
+2% +$7.94M 0.27% 50
2018
Q4
$358M Sell
4,915,569
-702,208
-12% -$49.6M 0.28% 49
2018
Q3
$380M Buy
5,617,777
+844,345
+18% +$53.8M 0.26% 56
2018
Q2
$276M Sell
4,773,432
-2,430,429
-34% -$137M 0.24% 60
2018
Q1
$374M Sell
7,203,861
-485,917
-6% -$26.2M 0.29% 61
2017
Q4
$413M Buy
7,689,778
+3,974,239
+107% +$220M 0.34% 50
2017
Q3
$227M Buy
3,715,539
+442,422
+14% +$26.8M 0.23% 55
2017
Q2
$200M Buy
3,273,117
+153,859
+5% +$9.37M 0.21% 62
2017
Q1
$189M Sell
3,119,258
-39,770
-1% -$2.41M 0.21% 67
2016
Q4
$177M Sell
3,159,028
-11,015
-0.3% -$645K 0.19% 76
2016
Q3
$189M Buy
3,170,043
+427,283
+16% +$25M 0.21% 61
2016
Q2
$151M Buy
2,742,760
+34,108
+1% +$1.82M 0.2% 78
2016
Q1
$134M Sell
2,708,652
-52,723
-2% -$2.58M 0.2% 77
2015
Q4
$137M Sell
2,761,375
-805,296
-23% -$40.6M 0.17% 106
2015
Q3
$167M Sell
3,566,671
-1,658,911
-32% -$88.1M 0.2% 73
2015
Q2
$279M Buy
5,225,582
+610,761
+13% +$34.3M 0.31% 31
2015
Q1
$251M Sell
4,614,821
-365,582
-7% -$20.7M 0.29% 41
2014
Q4
$266M Buy
4,980,403
+1,091,070
+28% +$60.8M 0.26% 54
2014
Q3
$219M Buy
3,889,333
+352,653
+10% +$19.8M 0.21% 61
2014
Q2
$192M Sell
3,536,680
-1,403,270
-28% -$76.6M 0.2% 60
2014
Q1
$264M Sell
4,939,950
-3,841,837
-44% -$199M 0.3% 45
2013
Q4
$419M Buy
8,781,787
+3,356,818
+62% +$153M 0.43% 23
2013
Q3
$243M Buy
5,424,969
+97,375
+2% +$4.45M 0.29% 36
2013
Q2
$236M Buy
+5,327,594
New +$238M 0.29% 41

Other funds holding MRK

Barclays's MRK Position: Q2 2026 in Review

Barclays reduced its Merck (MRK) stake by 10% in Q2 2026, selling an estimated $89.4M and leaving 6,793,897 shares worth $873M. The position accounts for 0.17% of the portfolio, ranked #78.

Barclays first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.14B in Q1 2024. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Barclays held 6,793,897 shares of Merck worth $873M as of Q2 2026.
  • Barclays sold 763,621 Merck shares in Q2 2026, an estimated $89.4M.
  • Merck made up 0.17% of Barclays's portfolio in Q2 2026, its #78 holding.
  • Barclays first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Merck position peaked at $1.14B in Q1 2024.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.